Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zoetis Inc. ZTS

Healthcare  —  Drug Manufacturers Specialty & Generic
71.05 0.78 1.11% as of 25 Sep
Market cap
$29.2B
P/E
11.7×
S&P 500 Member Dividend Champion (10y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zoetis Inc. (ZTS) P/B ratio

As of 25 September 2026, Zoetis Inc. (ZTS) trades at a P/B ratio of 9.4×. Over the past ten years it has ranged from 9.3× (September 2026) to 26.3× (September 2020); the current reading is higher than 0% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.9× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 16.3× 5.31%
FY2024 15.5× (14.58%)
FY2023 18.2× 16.14%
FY2022 15.6× (38.61%)
FY2021 25.5× 22.13%
FY2020 20.9× (10.74%)
FY2019 23.4× 23.57%
FY2018 18.9× (3.94%)
FY2017 19.7× 11.09%
FY2016 17.7× (19.26%)

Quarterly

Period P/B ratio Change
Jun 2026 9.5× (38.23%)
Mar 2026 15.4× (5.54%)
Dec 2025 16.3× 36.09%
Sep 2025 12.0× (13.92%)
42 more quarters

Against its own ten years

Low 9.3× High 26.3×
Ten-year median 18.2×
Current reading's percentile 0

P/B ratio against peers

Company P/B ratio
TAK Takeda Pharmaceutical Co. compare 1.3×
VTRS Viatris Inc. compare 1.5×
ELAN Elanco Animal Health Incorporated compare 1.7×
HLN Haleon PLC Sponsored ADR compare 1.9×
RDY Dr. Reddy's Laboratories Ltd compare 2.3×
UTHR United Therapeutics Corporation compare 3.2×
NBIX Neurocrine Biosciences, Inc. compare 3.8×
TEVA Teva Pharmaceutical Industries Ltd. compare 5.9×
ZTS Zoetis Inc. 9.4×
Drug Manufacturers Specialty & Generic industry median 1.9×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ZTS